Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M518101 Phase III 52-week Long-term Study in Plaque Psoriasis and Palmoplantar Keratoderma
jRCT2080222895Phase 3
- Sponsor
- Maruho Co., Ltd.
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pefcalcitol in plaque psoriasis and palmoplantar keratoderma (PPK), sponsored by Maruho Co., Ltd.
02
Drugs
pefcalcitol
03
Conditions
plaque psoriasispalmoplantar keratoderma (PPK)
Beyond the preview
Go deeper on jRCT2080222895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222895.